Anti-Pseudomonas Immune Status and Dendritic Cell Preparation in Normal Individuals
NCT00320164 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8
Last updated 2017-05-24
Summary
This protocol aims to collect human peripheral blood mononuclear cells for the production of dendritic cells (DC). There are two ways to collect human peripheral blood mononuclear cells in this protocol. One is by using the method of leukapheresis from normal healthy adults. The other is by drawing the blood from normal healthy adults and then getting the buffy coats from the blood.
Conditions
- Healthy
Sponsors & Collaborators
-
Weill Medical College of Cornell University
lead OTHER
Principal Investigators
-
Neil R. Hackett, Ph.D. · Weill Medical College of Cornell University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-01-31
- Primary Completion
- 2008-01-31
- Completion
- 2008-01-31
More Related Trials
-
Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy
NCT06435351 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Autologous Dendritic Cell Therapy for Type 1 Diabetes Suppression: A Safety Study
NCT00445913 ·Status: COMPLETED ·Phase: PHASE1
-
Plasmapheresis of Anthrax-Vaccinated Subjects for Production of Anthrax Immune Globulin
NCT00031291 ·Status: COMPLETED
-
Dendritic Cell Vaccination and Docetaxel for Patients With Prostate Cancer
NCT01446731 ·Status: COMPLETED ·Phase: PHASE2
-
Development of a Cell Culture Process for the Production of Human T-lymphocyte Precursors
NCT05118113 ·Status: UNKNOWN ·Phase: NA
-
Tumor RNA Transfected Dendritic Cell Vaccines
NCT00108264 ·Status: COMPLETED ·Phase: PHASE1
-
Dendritic Cell Based Therapy of Metastatic Breast Cancer
NCT00197925 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab
NCT05325632 ·Status: RECRUITING ·Phase: PHASE2
-
Analysis of Dendritic Phenotype and Function of Patients Receiving VEGF-Trap on VGFT-ST-0202
NCT00896662 ·Status: COMPLETED
-
Safety Study of Autologous Dendritic Cells Injected Into the Prostate After Cryoablation for Advanced Prostate Cancer
NCT00753220 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
CT7, MAGE-A3, and WT1 mRNA-electroporated Autologous Langerhans-type Dendritic Cells as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
NCT01995708 ·Status: COMPLETED ·Phase: PHASE1
-
Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain Tumors
NCT00576537 ·Status: COMPLETED ·Phase: PHASE2
-
Immune Cell Response to Stimuli
NCT00397280 ·Status: RECRUITING
-
Dendritic Cells in Patients With Acute or Chronic Skin Graft Versus Host Disease
NCT02611180 ·Status: ACTIVE_NOT_RECRUITING
-
Safety and Effectiveness of a Vaccine for Prostate Cancer That Uses Each Patients' Own Immune Cells.
NCT00289341 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Autologous Dendritic Cells Pulsed With Autologous Apoptotic Tumor Cells Administered to Patients With Brain Tumors
NCT00893945 ·Status: COMPLETED ·Phase: PHASE1
-
In Vitro Functional Modulation of Monocyte-derived Dendritic Cells of Patients With Cancer by Peptides
NCT02159937 ·Status: COMPLETED
-
A Study Evaluating Vaccination of Prostate Cancer Patients With Self Dendritic Cells Expressing MUC1
NCT00852007 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer
NCT03387553 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Dendritic Cell Based Therapy of Malignant Melanoma
NCT00197912 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Natural Dendritic Cell Vaccines in Metastatic Melanoma Patients
NCT01690377 ·Status: COMPLETED ·Phase: PHASE1
-
In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients
NCT00001336 ·Status: COMPLETED
-
Mature Dendritic Cell Vaccination Against Unique Immunogenic Peptides in Patients With Non Small Cell Lung Cancer (NSCLC)
NCT02419170 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells.
NCT00571389 ·Status: RECRUITING
-
Dendritic Cell Based Therapy of Renal Cell Carcinoma
NCT00197860 ·Status: COMPLETED ·Phase: PHASE1/PHASE2